Insmed Inc. (INSM) Appoints New VP to Guide the Company through Research and Development
Insmed Inc. (Nasdaq: INSM) develops follow-on biologics for the competitive biopharmaceuticals market. To continue strengthening its position in the industry, the company relies on its proprietary protein platform and a seasoned management team. The company today announced Jim Miller, Ph.D., as vice president of Process Development, a role in which Dr. Miller will help develop the company’s follow-on biologics portfolio. "We are excited to have Jim join our experienced team. His background is well suited to further accelerate progress on our follow-on biologics portfolio as we reach a critical stage in the development process of these product candidates,” Doug Farrar,…